Samrat Pharma

9
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
209.95
-17.8 (-7.82%)
BSENSE

Mar 12

BSE+NSE Vol: 8.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 1.52% vs -9.36% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 314.72% vs -89.68% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -1.88% vs -44.22% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 228.87% vs -87.00% in Mar 2024

Compare Profit and Loss Results of Samrat Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
285.00
83.00
202.00
243.37%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
285.00
83.00
202.00
243.37%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-1.00
-1.00
-100.00%
Raw Materials Consumed
269.00
38.00
231.00
607.89%
Power & Fuel Cost
1.00
6.00
-5.00
-83.33%
Employee Cost
2.00
11.00
-9.00
-81.82%
Operating Expenses
2.00
6.00
-4.00
-66.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
4.00
-4.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
275.00
71.00
204.00
287.32%
Operating Profit (PBDIT) excl Other Income
10.00
11.00
-1.00
-9.09%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
11.00
13.00
-2.00
-15.38%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
10.00
6.00
4.00
66.67%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
9.00
0.00
9.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
0.00
9.00
0%
Provision for Tax
2.00
0.00
2.00
0%
Profit After Tax
7.00
0.00
7.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
61.00
46.00
15.00
32.61%
Profit Available for appropriations
69.00
46.00
23.00
50.00%
Appropriations
69.00
46.00
23.00
50.00%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
23.02
0.2
22.82
11,410.00%
Profit And Loss - Net Sales
Net Sales 285.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.52% vs -9.36% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 314.72% vs -89.68% in Mar 2024

Profit And Loss - Interest
Interest 0.67 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1.88% vs -44.22% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 7.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 228.87% vs -87.00% in Mar 2024